Company Filing History:
Years Active: 1992-1993
Title: Shiu-Lok Hu: Innovator in Melanoma Vaccine Development
Introduction
Shiu-Lok Hu is a prominent inventor based in Redmond, WA (US). He has made significant contributions to the field of immunology, particularly in the development of vaccines targeting melanoma. With a total of 3 patents, his work focuses on innovative approaches to combat this aggressive form of skin cancer.
Latest Patents
Shiu-Lok Hu's latest patents include groundbreaking research on recombinant viruses encoding human melanoma-associated antigens. These patents describe peptides or proteins related to melanoma-associated antigens that are produced in large quantities using recombinant DNA techniques and chemical synthetic methods. The peptides or proteins serve as immunogens in vaccine formulations, which can induce an immune response that selectively destroys melanoma cells in vaccinated individuals. Additionally, where these peptides or proteins are expressed by a recombinant virus, both inactivated and live virus vaccine formulations may be prepared.
Career Highlights
Throughout his career, Shiu-Lok Hu has been associated with Oncogen, where he has focused on advancing cancer treatment through innovative vaccine development. His research has the potential to significantly impact the way melanoma is treated, offering new hope for patients.
Collaborations
Shiu-Lok Hu has collaborated with notable colleagues, including Joseph P Brown and Charles D Estin. These partnerships have contributed to the advancement of his research and the development of effective vaccine strategies.
Conclusion
Shiu-Lok Hu's work in the field of melanoma vaccine development exemplifies the importance of innovation in medical research. His contributions are paving the way for new therapeutic options in the fight against cancer.